http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2311806-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
| filingDate | 2004-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2009-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_916d914d55df2621b86f00f93e292da0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9acf1cfd32faec816f7f20608aa2089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7135b43f54db5fc5058d838eac38cd43 |
| publicationDate | 2009-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2311806-T3 |
| titleOfInvention | AZETIDINONA COMPOSITE SUBSTITUTED, FORNULATIONS AND USES OF THE SAME FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA. |
| abstract | A compound represented by structural formula (I): (See formula) or enantiomers, stereoisomers, rotamers, tautomers, racemates and geometric isomers, salts, solvates or pharmaceutically acceptable esters of the compound of Formula (I), in which in the Formula (I) above: X, Y and Z may be the same or different and each is independently selected from the group consisting of -CH2-, -CH (alkyl) - and -C (alkyl) 2-; Q 1 and Q 2 may be the same or different and each is independently selected from the group consisting of H, - (C0-C30 alkylene) -G, -OR 6, -OC (O) R 6, -OC (O) OR 9 -OC (O) NR 6 R 7, and -LM; Q 3 is 1 to 5 substituents independently selected from the group consisting of alkyl, alkenyl, alkynyl, - (C0-C30 alkylene) -G, - (C0-C10 alkylene) -OR 6, - (C0-C10 alkylene) - C (O) R, - (C0-C10 alkylene) -C (O) OR 6, - (C0-C10 alkylene) -OC (O) R 6, - (C0-C10 alkylene) -OC (O) OR 9 , -CH = CH-C (O) R 6, -CH = CH-C (O) OR 6, -C equiv CC (O) OR 6, -C equiv CC (O) R 6, -O- (alkylene C0-C10) -OR 6, -O- (C0-C10 alkylene) -C (O) R 6, -O- (C0-C10 alkylene) -C (O) OR 6, -CN, -O- (alkylene C0-C10) -C (O) NR 6 R 7, -O- (C0-C10 alkylene) -C (O) NR 6 NR 7 C (O) OR 6, -O- (C0-C10 alkylene) -C (O) (aryl) -NN = N-, -OC (O) - (C0-C10 alkylene) -C (O) OR 6, - (C0-C10 alkylene) -C (O) NR 6 R 7, - (C0-C10 alkylene) -OC (O) NR 6 R 7, -NO2, - (C0-C10 alkylene) -NR 6 R 7, -O- (C2-C10 alkylene) -NR 6 R 7, -NR 6 C (O) R 7, -NR 6 C (O) OR 9, -NR 6 C (O) NR 7 R 8, -NR 6 S (O) 0 - 2R 9, -N (S (O) 0 - 2R 9) 2, -CHNOR 6, -C (O) NR 6 R 7, -C (O) NR 6 NR 6 R 7, -S (O) 0 - 2NR 6 R 7, -S (O) 0 - 2R 9, -OC (O) - (C0-C10 alkylene) -C (O) NR 6 R 7, -OC (O) - (C0-C10 alkylene) -NR 6 C (O) O- (alkylaryl), -P (O) (OR 10) 2, - (C0-C10 alkylene) -OSi (alkyl) 3, -CF3, -OCF3, halo, alkoxyalkoxy, alkoxyalkoxyalkoxy, alkoxycarbonylalkoxy, alkoxyarylalkoxy, alkoxyiminoalkyl, alkyldioyl, allyloxy, aryl, arylalkyl, aryloxy, arylalkoxy, aroyl, aroyloxy, aroilaroiloxi, arylalkoxycarbonyl, benzoylbenzoyloxy, heteroaryl, heteroarylalkyl, heteroarylalkoxy, dioxolanyl, heterocyclyl, heterocyclylalkyl, heterocyclylcarbonyl, heterocyclylcarbonylalkoxy and -LM; Q 4 is 1 to 5 substituents independently selected from the group consisting of alkyl, alkenyl, alkynyl, - (C0-C30 alkylene) -G, - (C0-C10 alkylene) -OR 6, - (C0-C10 alkylene) - C (O) R 6, - (C0-C10 alkylene) -C (O) OR 6, - (C0-C10 alkylene) -OC (O) R 6, - (C0-C10 alkylene) -OC (O) OR 9, -CH = CH-C (O) R 6, -CH = CH-C (O) OR 6, -C CC (O) OR 6, -C CC (O) R 6, -O- (C0 alkylene -C10) -OR 6, -O- (C0-C10 alkylene) -C (O) R 6 -O- (C0-C10 alkylene) -C (O) OR 6, -CN, -O- (C0-alkylene) C10) -C (O) NR 6 R 7 -O- (C0-C10 alkylene) -C (O) NR 6 NR 7 C (O) OR 6, -O- (C0-C10 alkylene) -C (O) (aryl) -N- N = N-, -OC (O) - (C0-C10 alkylene) -C (O) OR 6, - (C0-C10 alkylene) -C (O) NR 6 R 7, - ( C0-C10 alkylene) -OC (O) NR 6 R 7, -NO2, - (C0-C10 alkylene) -NR 6 R 7, -O- (C2-C10 alkylene) -NR 6 R 7, -NR 6 C (O) R 7, -NR 6 C (O) OR 9, -NR 6 C (O) NR 7 R 8, -NR 6 S (O) 0 - 2R 9, -N (S (O) 0 - 2R 9) 2, -CHNOR 6, -C (O) NR 6 R 7, -C (O) NR 6 NR 6 R 7, -S (O) 0 - 2NR 6 R 7, -S (O) 0 - 2R 9, -OC (O) - (C0-C10 alkylene) -C (O) NR 6 R 7, -OC (O) - (al C0-C10) -NR 6 C (O) O- (alkylaryl), -P (O) (OR 10) 2, - (C0-C10 alkylene) - OSi (alkyl) 3, -CF3, -OCF3, halo , alkoxyalkoxy, alkoxyalkoxyalkoxy, alkoxycarbonylalkoxy, alkoxyarylalkoxy, alkoxyiminoalkyl, alkyldioyl, allyloxy, aryl, arylalkyl, aryloxy, arylalkoxy, aroyl, aroyloxy, aroilaroiloxi, arylalkoxycarbonyl, benzoylbenzoyloxy, heteroaryl, heteroarylalkyl, heteroarylalkoxy, dioxolanyl, heterocyclyl, heterocyclylalkyl, heterocyclylcarbonyl, Heterocyclylcarbonylalkoxy and - LM; Q 5 is ... |
| priorityDate | 2003-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1085.